I like to say 'show me the money,' and the drug industry is showing the money with their earnings. All three major drug firms today had good numbers.

The merger creates a Goliath. What they have done is created the best of the best.

This is a theme that I think investors are missing, because as tech and retail companies continue to warn about profit shortfalls, there are no revisions in the drug area.

One-hundred-ten years of history, great diversity, lots of new earnings drivers and I just became a grandpa -- twins. And I'm buying J&J, Pfizer and Warner for their future college funds.

The fundamentals for big pharmaceutical firms are fine. Cash is fine to support growth, and earnings are meeting the targets. I think investors are taking some of that for granted and ignoring it.

The schizophrenic mind is not so much split as shattered. I like to say schizophrenia is like a waking nightmare.